Case Report: Reversible cabergoline-associated cardiac valvulopathy post drug discontinuation
We present a case of a 21 year old male patient diagnosed with a 2.2 cm prolactin-secreting adenoma in contact with the optic chiasm. The patient was treated with up to 6mg/week of cabergoline (total cumulative dose 814 mg) and developed mild valvulopathy. Valvulopathy was subsequently reversed afte...
| Main Authors: | , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
F1000Research
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133764/ |